In prostate cancer, inhibiton of Cytohesin 1 by siRNA, reduces the pro-tumorigenic role of Insulin Growth Factor Receptor (IGFR) signaling (Weizhong et al., 2011), suggesting that this ARF GEF could be targeted to impair prostate cancer progression. The gene discussed is CDKN2A; the disease is Familial prostate cancer.